GO:1905317 inferior endocardial cushion morphogenesis: Developmental Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905317 (inferior endocardial cushion morphogenesis) describes the developmental process that generates and organizes the inferior (ventral) endocardial cushion, a critical precursor of the atrioventricular septum and valves [1, 4].
• This process is essential for proper heart looping and chamber septation, as shown in trisomy 16 mouse models where abnormal cushion development correlates with heart loop defects.
• The inferior endocardial cushion contributes to the formation of the tricuspid valve and atrioventricular septal structures, with disruptions leading to atrioventricular septal defects [2, 3, 4].
• Lineage tracing studies have revealed that endocardial cushion cells undergo epithelial-to-mesenchymal transition and migrate to form valve primordia.
• Deficiency of the vestibular spine, a derivative of the inferior cushion, is linked to atrioventricular septal defects in human fetuses with Down syndrome.
• Key developmental events include endocardial cell activation, cushion expansion, and remodeling, which are regulated by signaling pathways and transcription factors [1, 4, 5].
Description
The inferior endocardial cushion morphogenesis (GO:1905317) is a fundamental developmental process that shapes the ventral component of the endocardial cushions, which are transient embryonic structures critical for heart septation and valve formation [1, 4]. This process involves the coordinated generation and organization of the inferior cushion, a mesenchymal tissue that arises from endocardial cells through epithelial-to-mesenchymal transition (EMT). Proper inferior cushion morphogenesis is essential for the formation of the atrioventricular septum and the tricuspid valve, and its disruption leads to congenital heart defects such as atrioventricular septal defects [2, 3]. Researchers study this process to understand the molecular and cellular mechanisms underlying heart development and to identify therapeutic targets for congenital heart disease. The inferior cushion is distinct from the superior cushion, and its morphogenesis is influenced by heart looping architecture, as demonstrated in trisomy 16 mouse models. This article synthesizes current knowledge on the definition, mechanisms, key genes, and research methods for studying GO:1905317, providing a comprehensive resource for developmental biologists and clinicians.
inferior endocardial cushion morphogenesis At A Glance
| GO ID | GO:1905317 |
|---|---|
| GO term | inferior endocardial cushion morphogenesis |
| Ontology | biological_process |
| Synonym | ventral endocardial cushion morphogenesis |
| Major function | Generation and organization of the inferior endocardial cushion during heart development |
| Related structures | Atrioventricular septum, tricuspid valve, vestibular spine |
| Key cellular process | Epithelial-to-mesenchymal transition (EMT) of endocardial cells |
| Associated defects | Atrioventricular septal defects, Down syndrome-associated heart anomalies |
What Is GO:1905317?
According to the Gene Ontology, GO:1905317 (inferior endocardial cushion morphogenesis) is defined as the developmental process by which an inferior endocardial cushion is generated and organized. This process encompasses the cellular and molecular events that lead to the formation, growth, and shaping of the inferior (ventral) endocardial cushion, a mesenchymal structure in the embryonic heart. The synonym ventral endocardial cushion morphogenesis is also used. This term is a biological process and is distinct from other cushion morphogenesis terms, focusing specifically on the inferior cushion, which contributes to atrioventricular septation and valve development [1, 4].
Why Is inferior endocardial cushion morphogenesis Important in Cell Biology?
Understanding inferior endocardial cushion morphogenesis is crucial because this process is a cornerstone of proper heart septation and valve formation. Disruptions in the generation or organization of the inferior cushion lead to congenital heart defects, particularly atrioventricular septal defects, which are among the most common severe cardiac malformations [2, 3]. The inferior cushion gives rise to the vestibular spine, a structure whose deficiency is directly linked to atrioventricular septal defects in human fetuses with Down syndrome. Moreover, studies in mouse models have shown that abnormal cushion development is associated with heart loop architecture defects, highlighting the interplay between morphogenesis and overall cardiac patterning. Research into GO:1905317 not only illuminates fundamental developmental biology but also provides insights into the etiology of congenital heart disease, potentially guiding diagnostic and therapeutic strategies [4, 5].
• Critical for atrioventricular septation and tricuspid valve formation [2, 4].
• Disruption leads to atrioventricular septal defects, a major congenital heart anomaly [3, 6].
• Inferior cushion derivatives, such as the vestibular spine, are essential for septal closure.
• Abnormal cushion morphogenesis is linked to heart looping defects in trisomy 16 mice.
• Endocardial cushion cells undergo EMT, a model for studying cell fate transitions.
• Provides insights into Down syndrome-associated congenital heart disease.
• Serves as a paradigm for understanding mesenchymal tissue remodeling.
• Key to deciphering gene regulatory networks in heart development [1, 5].
• Relevant to regenerative medicine strategies for valve repair.
• Highlights the importance of spatiotemporal signaling in organogenesis.
What Happens During inferior endocardial cushion morphogenesis?
Initiation and Endocardial Cell Activation
In simple terms: The process starts when cells lining the heart tube receive signals to transform and migrate.
Inferior endocardial cushion morphogenesis begins with the activation of endocardial cells overlying the future atrioventricular canal. These cells receive inductive signals from the adjacent myocardium, leading to their specification and preparation for epithelial-to-mesenchymal transition (EMT) [1, 4]. In the trisomy 16 mouse model, altered heart loop architecture affects the positioning of the inferior cushion, suggesting that mechanical and spatial cues influence this initiation step. The endocardial cells lose their epithelial characteristics and gain migratory properties, a hallmark of cushion initiation.
Epithelial-to-Mesenchymal Transition (EMT) and Cell Migration
In simple terms: Endocardial cells change into mobile mesenchymal cells and move into the cushion matrix.
Following activation, endocardial cells undergo EMT, delaminating from the endocardial layer and migrating into the underlying extracellular matrix to form the cushion mesenchyme. This process is essential for the generation of the inferior cushion. Lineage tracing studies in mice have demonstrated that these mesenchymal cells are derived from the endocardium and contribute to valve and septal structures. The migration is guided by chemotactic signals and interactions with the extracellular matrix, and defects in EMT result in hypocellular cushions and subsequent malformations.
Cushion Expansion and Organization
In simple terms: The cushion grows and takes shape as more cells accumulate and arrange themselves.
After EMT, the inferior cushion expands through continued cell proliferation and recruitment of additional mesenchymal cells. The organization of the cushion involves the formation of a dense mesenchymal core surrounded by a layer of endocardium [1, 4]. In the normal mouse, the inferior cushion fuses with the superior cushion to form the atrioventricular septum, a critical step for separating the left and right sides of the heart. The vestibular spine, a derivative of the inferior cushion, extends to close the primary atrial septum. Disruptions in this expansion phase lead to septal defects, as seen in human fetuses with Down syndrome.
Remodeling and Valve Formation
In simple terms: The cushion is sculpted into mature valve leaflets and septal structures.
The final stage of inferior endocardial cushion morphogenesis involves remodeling of the cushion tissue into the tricuspid valve and the membranous part of the atrioventricular septum [2, 5]. This remodeling includes apoptosis, extracellular matrix reorganization, and differentiation of mesenchymal cells into valve interstitial cells. Studies in human embryos have detailed the formation of the tricuspid valve from the inferior cushion, highlighting the precise spatiotemporal regulation required. Defects in remodeling can result in valve stenosis or regurgitation, as well as septal defects.
Key Genes Involved in GO:1905317 inferior endocardial cushion morphogenesis
The following genes and proteins have been implicated in the regulation and execution of inferior endocardial cushion morphogenesis based on experimental studies in animal models and human tissue analyses.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Nkx2-5 | Transcription factor regulating heart development and cushion formation | Mutations linked to congenital heart defects; studied in mouse models |
| Tbx2 | Represses chamber-specific genes in the atrioventricular canal | Essential for cushion initiation; knockout leads to cushion defects |
| Tbx3 | Regulates conduction system and cushion development | Involved in atrioventricular canal patterning |
| Bmp2 | Signaling molecule inducing EMT in endocardial cells | Critical for cushion mesenchyme formation |
| Tgfbr2 | Receptor for TGF-beta signaling in cushion mesenchyme | Required for EMT and cushion remodeling |
| Notch1 | Regulates endocardial cell fate and EMT | Mutations associated with valve disease |
| Sox9 | Transcription factor in valve progenitor cells | Promotes mesenchymal proliferation and differentiation |
| Wnt/beta-catenin | Signaling pathway controlling cushion growth | Dysregulation leads to septal defects |
| Vegf | Angiogenic factor influencing cushion vascularization | Affects cushion remodeling |
| Has2 | Synthesizes hyaluronan in cushion matrix | Required for cushion expansion; knockout causes defects |
| Erbb3 | Receptor tyrosine kinase in cushion mesenchyme | Regulates cell survival and proliferation |
| Periostin | Extracellular matrix protein in cushion remodeling | Important for valve maturation |
| Cathepsin K | Protease involved in cushion remodeling | Expressed in valve interstitial cells |
| Mmp2 | Matrix metalloproteinase for ECM degradation | Facilitates cushion remodeling |
| Tie2 | Endothelial receptor for angiopoietin signaling | Regulates cushion angiogenesis |
| Nfatc1 | Transcription factor in endocardial cells | Controls EMT and cushion formation |
| Sema3c | Guidance molecule for cushion cell migration | Influences outflow tract and cushion patterning |
| Pdgfrb | Receptor for platelet-derived growth factor | Regulates mesenchymal cell proliferation |
How Is inferior endocardial cushion morphogenesis Regulated?
The regulation of inferior endocardial cushion morphogenesis involves a complex interplay of signaling pathways, transcription factors, and mechanical forces. Key pathways include TGF-beta/BMP, Notch, Wnt/beta-catenin, and VEGF signaling, which control EMT, proliferation, and differentiation of cushion cells [4, 5]. Transcription factors such as Nkx2-5, Tbx2, and Tbx3 establish the atrioventricular canal identity and restrict cushion formation to specific regions [1, 4]. Additionally, hemodynamic forces generated by heart looping influence cushion positioning and shape, as evidenced by studies in trisomy 16 mice where altered loop architecture correlates with abnormal inferior cushion development. Epigenetic regulators and microRNAs also modulate gene expression during cushion morphogenesis, though specific mechanisms remain under investigation.
inferior endocardial cushion morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Vestibular spine (derived from inferior cushion) | Atrioventricular septal defects in Down syndrome | Human fetal tissue analysis; mouse models of trisomy 21 |
| Tbx2 | Atrioventricular canal defects | Tbx2 knockout mouse; conditional deletion |
| Bmp2 | Cushion hypoplasia and septal defects | Bmp2 conditional knockout in endocardium |
| Has2 | Defective cushion expansion and AVSD | Has2 null mouse; hyaluronan synthase mutants |
| Nkx2-5 | Congenital heart defects including AVSD | Nkx2-5 haploinsufficient mouse; human mutation screening |
Atrioventricular Septal Defects (AVSD)
Atrioventricular septal defects are among the most common congenital heart malformations and are directly linked to abnormal inferior endocardial cushion morphogenesis. In human fetuses with Down syndrome, deficiency of the vestibular spine, a derivative of the inferior cushion, leads to incomplete atrial and ventricular septation. Developmental studies in humans have shown that failure of the inferior cushion to fuse with the superior cushion results in a common atrioventricular junction, characteristic of AVSD. Mouse models with disrupted cushion formation also exhibit AVSD-like phenotypes, underscoring the evolutionary conservation of this process.
Tricuspid Valve Anomalies
The inferior endocardial cushion is a primary source of the tricuspid valve leaflets. Disruptions in its morphogenesis can lead to tricuspid valve stenosis or regurgitation. Human embryonic studies have detailed the formation of the tricuspid valve from the inferior cushion, and deviations from this normal developmental sequence are associated with valve dysplasia. In trisomy 16 mice, abnormal cushion development correlates with heart loop defects that may impair tricuspid valve formation. Understanding these mechanisms is crucial for diagnosing and treating congenital valve diseases.
Down Syndrome-Associated Congenital Heart Disease
Individuals with Down syndrome (trisomy 21) have a high incidence of congenital heart defects, particularly atrioventricular septal defects. A key anatomical feature is the deficiency of the vestibular spine, which is derived from the inferior endocardial cushion. This deficiency leads to incomplete septation and a common atrioventricular valve. Research into the molecular basis of inferior cushion morphogenesis in Down syndrome models may reveal targets for intervention.
From inferior endocardial cushion morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate inferior cushion EMT? | Endothelial-specific knockout of gene X in mouse (e.g., Tie2-Cre) |
| What is the role of a specific point mutation in cushion morphogenesis? | Knock-in mouse carrying the point mutation; compare with wild-type |
| How does a human variant affect cushion development? | Knock-in of human variant into mouse genome; phenotypic analysis |
| Where is protein X expressed during inferior cushion formation? | Tagged knock-in (e.g., GFP) for live imaging and co-localization |
| Does overexpression of gene Y cause cushion hyperplasia? | Transgenic overexpression under endocardial-specific promoter |
| Can we rescue cushion defects by modulating gene Z? | Inducible overexpression or CRISPR activation in mouse models |
How to Study the inferior endocardial cushion morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing (Cre-lox) | Cell fate and migration | Tracking endocardial contribution to inferior cushion |
| Immunofluorescence | Protein localization and tissue architecture | Visualizing cushion markers in embryonic sections |
| Single-cell RNA-seq | Transcriptional profiles of individual cells | Identifying cushion cell subpopulations |
| In situ hybridization | mRNA expression patterns | Localizing gene expression in developing heart |
| Optical coherence tomography | 3D morphology of cushion and heart loops | Quantifying cushion volume in mutant mice |
| Whole-mount confocal imaging | Dynamic cell movements | Live imaging of EMT in cushion explants |
| Chromatin immunoprecipitation (ChIP) | Transcription factor binding sites | Mapping Nkx2-5 or Tbx2 targets in cushion |
| CRISPR-Cas9 genome editing | Gene function via knockout or knock-in | Creating models to test candidate genes |
Lineage Tracing and Genetic Fate Mapping
Lineage tracing using Cre-lox systems in mice allows researchers to follow the fate of endocardial cells that contribute to the inferior cushion. For example, Tie2-Cre or Nfatc1-Cre lines have been used to label endocardial cells and track their migration and differentiation into cushion mesenchyme and valve structures. This method is essential for understanding the cellular origins of the inferior cushion and how specific gene mutations alter cell fate.
Histology and Immunofluorescence
Histological sections of embryonic hearts at various stages, combined with immunofluorescence for markers such as Nfatc1, Sox9, and activated Notch, reveal the spatiotemporal organization of the inferior cushion. Studies in human embryos have used these techniques to detail the formation of the tricuspid valve and the vestibular spine [2, 6]. This approach is fundamental for phenotyping mutant models and human pathological specimens.
Transcriptomics and Single-Cell RNA Sequencing
RNA sequencing of microdissected inferior cushions or single cells from the atrioventricular canal can identify gene expression programs driving cushion morphogenesis. Comparative transcriptomics between normal and mutant embryos (e.g., trisomy 16) has highlighted pathways such as TGF-beta and Wnt signaling [1, 4]. Single-cell RNA-seq is particularly powerful for resolving heterogeneity within the cushion mesenchyme and endocardium.
In Vivo Imaging and Morphometrics
Live imaging of fluorescently labeled hearts in zebrafish or mouse embryos enables dynamic visualization of cushion formation and heart looping. Optical coherence tomography and light-sheet microscopy have been used to quantify cushion volume and shape in trisomy 16 mice, linking heart loop architecture to inferior cushion positioning. These methods provide quantitative data on morphogenetic movements.
How CRISPR Can Be Used to Study GO:1905317 inferior endocardial cushion morphogenesis
Knockout
CRISPR-Cas9 knockout of candidate genes in mouse or human induced pluripotent stem cell (iPSC)-derived cardiac organoids can reveal their requirement for inferior endocardial cushion morphogenesis. For example, knocking out Tbx2 or Has2 in mice results in cushion defects, and CRISPR can accelerate the generation of such models. Endothelial-specific knockout using conditional CRISPR alleles allows precise spatial control.
Point Mutation
Introducing specific point mutations associated with human congenital heart disease into the mouse genome or iPSCs via CRISPR base editing or homology-directed repair enables functional assessment of variants. For instance, mutations in Nkx2-5 identified in patients can be modeled to test their impact on inferior cushion development. This approach helps distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of reporter genes (e.g., GFP, lacZ) or human disease alleles into the endogenous locus allows visualization of gene expression and tracking of cushion cells. CRISPR-mediated knock-in of a fluorescent tag into the Nfatc1 locus, for example, enables live imaging of endocardial EMT. Knock-in of human variants into mouse models can recapitulate disease phenotypes.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to study the effects of increased gene dosage on inferior cushion morphogenesis. Overexpression of Bmp2 or Wnt ligands in the endocardium may lead to cushion hyperplasia or ectopic cushion formation, providing insights into signaling thresholds. These models are valuable for testing gain-of-function mechanisms in disease.
How EDITGENE Supports inferior endocardial cushion morphogenesis Research
Researchers studying inferior endocardial cushion morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the process or is merely a bystander. This requires precise genetic manipulation in relevant model systems, such as mouse embryos or human iPSC-derived cardiac tissues. EDITGENE provides a suite of CRISPR-based services to accelerate such investigations, from generating knockout lines to creating point mutations and knock-in reporters.
Contact EDITGENE today to design your custom CRISPR model for inferior endocardial cushion morphogenesis research.
Frequently Asked Questions About inferior endocardial cushion morphogenesis
What is GO:1905317?
GO:1905317 is the Gene Ontology term for inferior endocardial cushion morphogenesis, the developmental process that generates and organizes the inferior (ventral) endocardial cushion in the embryonic heart [1, 4].
What genes are involved in inferior endocardial cushion morphogenesis?
Key genes include Nkx2-5, Tbx2, Tbx3, Bmp2, Tgfbr2, Notch1, Sox9, Has2, and others that regulate EMT, proliferation, and remodeling of the cushion [1, 4, 5].
What is the function of the inferior endocardial cushion?
The inferior endocardial cushion contributes to the formation of the atrioventricular septum and the tricuspid valve, and its derivative, the vestibular spine, is essential for septal closure [2, 4, 6].
How does inferior endocardial cushion morphogenesis relate to congenital heart disease?
Disruptions in this process lead to atrioventricular septal defects, tricuspid valve anomalies, and are particularly associated with Down syndrome-associated heart defects [3, 6].
What animal models are used to study inferior endocardial cushion morphogenesis?
Mouse models, especially trisomy 16 and targeted knockouts, are widely used, along with zebrafish and human iPSC-derived cardiac organoids [1, 4, 5].
What signaling pathways regulate inferior endocardial cushion morphogenesis?
TGF-beta/BMP, Notch, Wnt/beta-catenin, and VEGF signaling pathways are critical regulators of cushion EMT, proliferation, and remodeling [4, 5].
What is the role of EMT in inferior endocardial cushion morphogenesis?
Epithelial-to-mesenchymal transition (EMT) is the process by which endocardial cells delaminate and migrate into the cushion matrix to form mesenchyme, a key step in cushion generation.
How can CRISPR be used to study inferior endocardial cushion morphogenesis?
CRISPR can create knockout, point mutation, knock-in, and overexpression models in mice or iPSCs to test gene function and model human variants associated with cushion defects [1, 4, 5].
What is the vestibular spine and how does it relate to GO:1905317?
The vestibular spine is a derivative of the inferior endocardial cushion that is deficient in atrioventricular septal defects in Down syndrome, highlighting the clinical relevance of this process.
What research methods are used to study inferior endocardial cushion morphogenesis?
Methods include lineage tracing, immunofluorescence, single-cell RNA-seq, in vivo imaging, and CRISPR screens to dissect cellular and molecular mechanisms [1, 2, 5].
Conclusion
Inferior endocardial cushion morphogenesis (GO:1905317) is a critical developmental process that underpins proper heart septation and valve formation. Its disruption leads to severe congenital heart defects, particularly atrioventricular septal defects, as seen in Down syndrome and other genetic syndromes. Research using animal models and human tissues has elucidated key genes and signaling pathways, but many questions remain. Advanced CRISPR technologies and multi-omics approaches promise to accelerate discoveries in this field, offering hope for new therapeutic strategies.
References
- 1. Webb S et al.. 1996. Endocardial cushion development and heart loop architecture in the trisomy 16 mouse.. Dev Dyn 206(3):301-9 PMID: 8896985
- 2. Lamers WH et al.. 1995. Formation of the tricuspid valve in the human heart.. Circulation 91(1):111-21 PMID: 7805192
- 3. Wenink AC et al.. 1988. Developmental aspects of atrioventricular septal defects.. Int J Cardiol 18(1):65-78 PMID: 3343065
- 4. Webb S et al.. 1998. Formation of the atrioventricular septal structures in the normal mouse.. Circ Res 82(6):645-56 PMID: 9546373
- 5. de Lange FJ et al.. 2004. Lineage and morphogenetic analysis of the cardiac valves.. Circ Res 95(6):645-54 PMID: 15297379
- 6. Blom NA et al.. 2003. Deficiency of the vestibular spine in atrioventricular septal defects in human fetuses with down syndrome.. Am J Cardiol 91(2):180-4 PMID: 12521631
